Search

Conservation treatment of degraded archaeological osseous materials is still an open challenge, since no specific conservation protocol is currently available for restorers or museum curators. This work aims to test the efficiency of two original consolidant solutions in consolidating archaeological material. Archaeological osseous materials remain rare and sparsely available, it is a real drawback for optimization of conservation treatments, therefore in the present work a set of representative samples was chosen. The consolidants tested were a solution of disodium sebacate and a novel polyalcohol (SG1.2) obtained by esterification of 5 succinic diacids with 6 molecules of glycerol at 150°C. Characterization studies of archaeological bones, combining SEM microscopy, IR spectroscopy and high‐resolution solid‐state 13C NMR investigations, have been carried out to assess the effective permeation of bone by the consolidant solutions and to determine their chemical interactions with the residual components of archaeological bones. Although both water solutions significantly impregnate bone, we show that, the solution with disodium sebacate leads to chemical attack on the mineral component due to preferential precipitation of endogenous calcium by the sebacate ions. Such deleterious behaviour is not observed at all with the SG1,2 chemicals. The added value of the polyalcohol treatment as strengthening agent suitable for archaeological bony materials should be further demonstrated by mechanical and ageing tests. [ABSTRACT FROM AUTHOR]

During chronic liver injury, hepatic stellate cells (HSC) are activated and proliferate, which causes excessive extracellular matrix (ECM) deposition, leading to scar formation and fibrosis. Medicinal plants are gaining popularity as antifibrotic agents, and are often safe, cost-effective, and versatile. This review aims to describe the protective role and mechanisms of medicinal plants in the inhibition of HSC activation and ECM deposition during the pathogenesis of liver fibrosis. A systematic literature review on the anti-fibrotic mechanisms of hepatoprotective plants was performed in PubMed, which yielded articles about twelve relevant plants. Many of these plants act via disruption of the transforming growth factor beta 1 signaling pathway, possibly through reduction in oxidative stress. This reduction could explain the inhibition of HSC activation and reduction in ECM deposition. Medicinal plants could be a source of anti-liver fibrosis compounds. [ABSTRACT FROM AUTHOR]

Extracellular vesicles (EVs), including exosomes, modulate multiple aspects of cancer biology. Tumor-associated macrophages (TAMs) secrete EVs, but their molecular features and functions are poorly characterized. Here, we report methodology for the enrichment, quantification, and proteomic and lipidomic analysis of EVs released from mouse TAMs (TAM-EVs). Compared to source TAMs, TAM-EVs present molecular profiles associated with a Th1/M1 polarization signature, enhanced inflammation and immune response, and a more favorable patient prognosis. Accordingly, enriched TAM-EV preparations promote T cell proliferation and activation ex vivo. TAM-EVs also contain bioactive lipids and biosynthetic enzymes, which may alter pro-inflammatory signaling in the cancer cells. Thus, whereas TAMs are largely immunosuppressive, their EVs may have the potential to stimulate, rather than limit, anti-tumor immunity. • Macrophages produce abundant extracellular vesicles in tumors • Macrophage-derived extracellular vesicles (TAM-EVs) display unique proteomic profiles • TAM-EVs enhance thromboxane synthesis in cancer cells • TAM-EVs promote, rather than limit, T cell proliferation and activation Cianciaruso et al. develop methods for the analysis of extracellular vesicles secreted by macrophages in mouse tumors (TAM-EVs). Proteomic and lipidomic profiling indicates that TAM-EVs carry modulators of inflammation and lipid metabolism that could influence the properties of the tumor immune microenvironment. [ABSTRACT FROM AUTHOR]

The Lyα Reference Sample (LARS) is a substantial program with the Hubble Space Telescope (HST) that provides a sample of local universe laboratory galaxies in which to study the detailed astrophysics of the visibility and strength of the Lyαline of neutral hydrogen. Lyα is the dominant spectral line in use for characterizing high-redshift (z) galaxies. This paper presents an overview of the survey, its selection function, and HST imaging observations. The sample was selected from the combined GALEX+Sloan Digital Sky Survey catalog at z = 0.028-0.19, in order to allow Lyα to be captured with combinations of long-pass filters in the Solar Blind Channel (SBC) of the Advanced Camera for Surveys (ACS) onboard HST. In addition, LARS utilizes Hα and Hβ narrowband and u, b, i broadband imaging with ACS and the Wide Field Camera 3 (WFC3). In order to study galaxies in which large numbers of Lyα photons are produced (whether or not they escape), we demanded an Hα equivalent width W(Hα) ⩾100 Å. The final sample of 14 galaxies covers far-UV (FUV, λ ∼ 1500 Å) luminosities that overlap with those of high-z Lyα emitters (LAEs) and Lyman break galaxies (LBGs), making LARS a valid comparison sample. We present the reduction steps used to obtain the Lyα images, including our LARS eXtraction software (LaXs), which utilizes pixel-by-pixel spectral synthesis fitting of the energy distribution to determine and subtract the continuum at Lyα. We demonstrate that the use of SBC long-pass-filter combinations increase the signal-to-noise ratio by an order of magnitude compared to the nominal Lyα filter available in SBC. To exemplify the science potential of LARS, we also present some first results for a single galaxy, Mrk 259 (LARS #1). This irregular galaxy shows bright and extended (indicative of resonance scattering) but strongly asymmetric Lyα emission. Spectroscopy from the Cosmic Origins Spectrograph on board HST centered on the brightest UV knot shows a moderate outflow in the neutral interstellar medium (probed by low ionization stage absorption features) and Lyα emission with an asymmetric profile. Radiative transfer modeling is able to reproduce the essential features of the Lyα line profile and confirms the presence of an outflow. From the integrated photometry we measure an Lyα luminosity of LLyα=1.3 × 1042 erg s–1 an equivalent width W(Lyα) = 45 Å and an FUV absolute magnitude MFUV = –19.2 (AB). Mrk 259 would hence be detectable in high-z Lyα and LBG surveys. The total Lyα escape fraction is 12%. This number is higher than the low-z average, but similar to that at z > 4, demonstrating that LARS provides a valid comparison sample for high-z galaxy studies. [ABSTRACT FROM AUTHOR]

Neutrophils accumulate in solid tumors, and their abundance correlates with poor prognosis. Neutrophils are not homogeneous, however, and could play different roles in cancer therapy. Here, we investigate the role of neutrophils in immunotherapy, leading to tumor control. We show that successful therapies acutely expanded tumor neutrophil numbers. This expansion could be attributed to a Sell hi state rather than to other neutrophils that accelerate tumor progression. Therapy-elicited neutrophils acquired an interferon gene signature, also seen in human patients, and appeared essential for successful therapy, as loss of the interferon-responsive transcription factor IRF1 in neutrophils led to failure of immunotherapy. The neutrophil response depended on key components of anti-tumor immunity, including BATF3-dependent DCs, IL-12, and IFNγ. In addition, we found that a therapy-elicited systemic neutrophil response positively correlated with disease outcome in lung cancer patients. Thus, we establish a crucial role of a neutrophil state in mediating effective cancer therapy. [Display omitted] • Neutrophils can acutely accumulate in tumors during successful immunotherapy • Therapy expands a distinct neutrophil state with an IFN-stimulated gene signature • The neutrophil response requires IRF1 and supports tumor control • Therapy-elicited neutrophil response in patients is associated with better outcome Successful cancer immunotherapy is associated with high numbers of neutrophils and expression of IRF1. [ABSTRACT FROM AUTHOR]

Conservation treatment of degraded archaeological osseous materials is still an open challenge, since no specific conservation protocol is currently available for restorers or museum curators. This work aims to test the efficiency of two original consolidant solutions in consolidating archaeological material. Archaeological osseous materials remain rare and sparsely available, it is a real drawback for optimization of conservation treatments, therefore in the present work a set of representative samples was chosen. The consolidants tested were a solution of disodium sebacate and a novel polyalcohol (SG1.2) obtained by esterification of 5 succinic diacids with 6 molecules of glycerol at 150°C. Characterization studies of archaeological bones, combining SEM microscopy, IR spectroscopy and high-resolution solid-state 13 C NMR investigations, have been carried out to assess the effective permeation of bone by the consolidant solutions and to determine their chemical interactions with the residual components of archaeological bones. Although both water solutions significantly impregnate bone, we show that, the solution with disodium sebacate leads to chemical attack on the mineral component due to preferential precipitation of endogenous calcium by the sebacate ions. Such deleterious behaviour is not observed at all with the SG1,2 chemicals. The added value of the polyalcohol treatment as strengthening agent suitable for archaeological bony materials should be further demonstrated by mechanical and ageing tests., (© 2020 John Wiley & Sons, Ltd.)

Macrophages modulate tumor response to chemotherapy; in this issue, Lossos and colleagues show that high-dose alkylating agents instigate a synthetic lethal program in lymphoma cells that is independent of DNA damage and involves recruitment and priming of macrophages for antibody-mediated tumor phagocytosis. These findings implicate chemotherapy-elicited macrophages as critical effectors of lymphoma clearance during biological therapy. See related article by Lossos et al., p. 944 ., (©2019 American Association for Cancer Research.)

There is a need for new noninvasive biomarkers (NIBMs) able to assess cholestasis and fibrosis in chronic cholestatic liver diseases (CCLDs). Tumorigenesis can arise from CCLDs. Therefore, autoantibodies to tumor-associated antigens (TAA) may be early produced in response to abnormal self-antigen expression caused by cholestatic injury. Vascular endothelial growth factor receptor-3 (VEGFR-3) has TAA potential since it is involved in cholangiocytes and lymphatic vessels proliferations during CCLDs. This study aims to detect autoantibodies directed at VEGFR-3 during bile duct ligation- (BDL-) induced cholestatic injury in rat sera and investigate whether they could be associated with traditional markers of liver damage, cholestasis, and fibrosis. An ELISA was performed to detect anti-VEGFR-3 autoantibodies in sera of rats with different degree of liver injury and results were correlated with aminotransferases, total bilirubin, and the relative fibrotic area. Mean absorbances of anti-VEGFR-3 autoantibodies were significantly increased from week one to week five after BDL. The highest correlation was observed with total bilirubin (R (2) = 0.8450, P = 3.04e - 12). In conclusion, anti-VEGFR-3 autoantibodies are early produced during BDL-induced cholestatic injury, and they are closely related to cholestasis, suggesting the potential of anti-VEGFR-3 autoantibodies as NIBMs of cholestasis in CCLDs and justifying the need for further investigations in patients with CCLD.